Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Cash on Hand 2019–2025
Recursion Pharmaceuticals, Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Recursion Pharmaceuticals, Inc. cash on hand as of December 31, 2025: 743.3M, a 25.06% increase year-over-year.
- Recursion Pharmaceuticals, Inc. cash on hand for 2025 were 743.3M, a 25.06% increase from 2024.
- Recursion Pharmaceuticals, Inc. cash on hand for 2024 were 594.4M, a 51.79% increase from 2023.
- Recursion Pharmaceuticals, Inc. cash on hand for 2023 were 391.6M, a 28.79% decrease from 2022.
- Recursion Pharmaceuticals, Inc. cash on hand for 2022 were 549.9M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Recursion Pharmaceuticals, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $743 |
| 2024 | $594 |
| 2023 | $392 |
| 2022 | $550 |
| 2021 | $285 |
| 2020 | $262 |
Recursion Pharmaceuticals, Inc. Cash on Hand — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's cash on hand history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s cash on hand by year and by quarter, including the growth rate.